Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Nour

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Genes, Brain, and Behavior|July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging studyTarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Neuroimage. Clinical|July 30, 2023
Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [<sup>11</sup>C]-carfentanil PET and fMRI studyEkaterina Shatalina, Abhishekh H Ashok, Matthew B Wall, et al.
JAMA Psychiatry|October 20, 2017
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and SchizophreniaSameer Jauhar, Matthew M Nour, Mattia Veronese, et al.
The International Journal of Neuropsychopharmacology|February 19, 2024
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy ControlsAtheeshaan Arumuham, Matthew M Nour, Mattia Veronese, et al.
Psychopharmacology|December 22, 2024
Working memory processes and the histamine-3 receptor in schizophrenia: a [<sup>11</sup>C]MK-8278 PET-fMRI studyAtheeshaan Arumuham, Ekaterina Shatalina, Matthew M Nour, et al.
Psychopharmacology|September 12, 2022
The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophreniaStephen J Kaar, Ilinca Angelescu, Matthew M Nour, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2018
Dopaminergic basis for signaling belief updates, but not surprise, and the link to paranoiaMatthew M Nour, Tarik Dahoun, Philipp Schwartenbeck, et al.
Molecular Psychiatry|April 22, 2018
Determinants of treatment response in first-episode psychosis: an <sup>18</sup>F-DOPA PET studySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Neuron|August 10, 2024
Internal world models in humans, animals, and AIIlka Diester, Marlene Bartos, Joschka Bödecker, et al.
Biological Psychiatry|August 21, 2018
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography StudySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Genes, Brain, and Behavior|July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging studyTarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Neuroimage. Clinical|July 30, 2023
Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [<sup>11</sup>C]-carfentanil PET and fMRI studyEkaterina Shatalina, Abhishekh H Ashok, Matthew B Wall, et al.
JAMA Psychiatry|October 20, 2017
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and SchizophreniaSameer Jauhar, Matthew M Nour, Mattia Veronese, et al.
The International Journal of Neuropsychopharmacology|February 19, 2024
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy ControlsAtheeshaan Arumuham, Matthew M Nour, Mattia Veronese, et al.
Psychopharmacology|December 22, 2024
Working memory processes and the histamine-3 receptor in schizophrenia: a [<sup>11</sup>C]MK-8278 PET-fMRI studyAtheeshaan Arumuham, Ekaterina Shatalina, Matthew M Nour, et al.
Psychopharmacology|September 12, 2022
The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophreniaStephen J Kaar, Ilinca Angelescu, Matthew M Nour, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2018
Dopaminergic basis for signaling belief updates, but not surprise, and the link to paranoiaMatthew M Nour, Tarik Dahoun, Philipp Schwartenbeck, et al.
Molecular Psychiatry|April 22, 2018
Determinants of treatment response in first-episode psychosis: an <sup>18</sup>F-DOPA PET studySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Neuron|August 10, 2024
Internal world models in humans, animals, and AIIlka Diester, Marlene Bartos, Joschka Bödecker, et al.
Biological Psychiatry|August 21, 2018
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography StudySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Pageof 7